Acute myeloid leukemia (AML) is a hematologic malignancy characterized by a disruption in normal hematopoiesis that results in uninhibited myeloblast proliferation. Cutaneous reactions in AML include leukemia cutis, Sweet syndrome, infections, and treatment-related effects. We present 3 cases of FLT3 (OMIM 136351) inhibitor-associated neutrophilic dermatoses (Table ).
No takes yet. Share an insight, caveat, or question.
Varadarajan et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: